These studies confirmed a critical role of astrocytic Cx43 in causing neuronal damage in the AD model, suggesting that astrocytic Cx hemichannels function could be a possible therapeutic target of AD (Figure 2). This evidence concerns the gene GJA1 and Alzheimer disease.